Belite Bio, INC Form 4 insider transactions

NASDAQ
Chief Scientific Officer Nathan L. Mata vested 144,868 stock options following the achievement of performance criteria.
NASDAQ
CEO Yu-Hsin Lin of Belite Bio, Inc. reported the vesting of 206,954 stock options following the achievement of performance criteria.